Aerska Secures $21 Million Seed Round to Advance RNAi Therapies for Neurodegenerative Diseases
Irish biotechnology startup Aerska has secured $21 million in seed funding to accelerate its pioneering work in RNA interference (RNAi) medicines aimed at treating degenerative brain…